Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Under promise and

<< Previous

Bullboard Posts

Next >>

Comment by Domino55on Dec 08, 2021 7:52pm

117 Views

Post# 34212702

RE:RE:RE:RE:RE:RE:Under promise and

The share price has managed to drop to near worthless with the Baxter relationship in hand. What is to say it won't be the same with a DaVita deal? Since the inception of the company what milestone has led to a sustained share price increase? None...It is 23 cents bud.

BTW You forgot to comment on the 2% NPV valuation or if you prefer all time lows.

<< Previous

Bullboard Posts

Next >>

dynaCERT leans into global growth with new HydraGEN orders